C3 Ventures

About The Fund

C3 Ventures is an angel investment firm specializing in early-stage ventures, with a keen interest in companies poised to redefine categories within their respective industries. They offer early funding opportunities for startups that demonstrate potential to lead in their markets. C3 Ventures operates with a specific focus on several key sectors: Software, including marketplaces and SaaS models; HealthTech and Fitness; Healthcare and Wellness; Mobility; and the Consumer space. Their investment approach is to engage with pre-seed and seed-stage companies, with a minimum investment limit of $100,000 and a maximum of $1,000,000. The sweet spot for their investment typically lies at around $500,000. C3 Ventures' investment thesis revolves around supporting category-defining startups that are not only innovative but also scalable and poised for significant impact. The company boasts successful collaborations, such as FemtoVox's alliance with Mayo Clinic and other prominent ventures like VenoStent, Vivifi Medical, and Givefront, which have achieved substantial growth and recognition. C3 Ventures has also celebrated the achievements of portfolio companies like Trestle Biotherapeutics, which won the prestigious $1M KidneyX Prize, and Carbon Chain and Living Carbon, who secured notable funding rounds. They are active in advancing diversity within the venture funding ecosystem and take pride in their portfolio companies' milestones, such as Momentus achieving a valuation of $1.2 billion. Led by a team of experienced professionals, including co-founders with strong backgrounds in technology and successful histories at firms like LinkedIn and Connectifier, C3 Ventures brings a wealth of knowledge and a robust network to the startups they invest in. Through a well-defined investment process, C3 Ventures partners, located in various strategic locations, aim to identify and elevate startups that have the potential to disrupt their industries and lead the way in innovation.